The ROE as of July 2025 (TTM) for Ligand Pharmaceuticals Incorporated (LGND) is -16.36%

According to Ligand Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current ROE is -16.36%. This represents a change of 293.56% compared to the average of -4.16% of the last 4 quarters.

Ligand Pharmaceuticals Incorporated (LGND) Historical ROE (quarterly & annually)

How has LGND ROE performed in the past?

The mean historical ROE of Ligand Pharmaceuticals Incorporated over the last ten years is 20.73%. The current -16.36% ROE has changed -178.93% with respect to the historical average. Over the past ten years (40 quarters), LGND's ROE was at its highest in in the September 2015 quarter at 68.16%. The ROE was at its lowest in in the December 2018 quarter at -7.57%.

Ligand Pharmaceuticals Incorporated (LGND) ROE by Quarter and Year

Discovering the peaks and valleys of Ligand Pharmaceuticals Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ligand Pharmaceuticals Incorporated (LGND) Average ROE

How has LGND ROE performed in the past?

The current ROE of Ligand Pharmaceuticals Incorporated (LGND) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ligand Pharmaceuticals Incorporated (LGND) ROE vs. Peers

How is LGND’s ROE compared to its peers?

Ligand Pharmaceuticals Incorporated’s ROE is greater than Passage Bio, Inc. (-93.59%), greater than ORIC Pharmaceuticals, Inc. (-51.14%), greater than Lyell Immunopharma, Inc. (-73.66%), greater than Design Therapeutics, Inc. (-22.85%), less than Ascendis Pharma A/S (191.42%), greater than Apellis Pharmaceuticals, Inc. (-100.06%), greater than BeiGene, Ltd. (-11.51%), greater than Akero Therapeutics, Inc. (-31.98%), greater than Blueprint Medicines Corporation (-48.89%), greater than Viridian Therapeutics, Inc. (-49.08%), greater than Terns Pharmaceuticals, Inc. (-28.81%), greater than Structure Therapeutics Inc. (-16.35%), greater than 89bio, Inc. (-81.44%), greater than Crinetics Pharmaceuticals, Inc. (-30.95%), less than Cytokinetics, Incorporated (801.26%), greater than Icosavax, Inc. (-35.64%), greater than Arcus Biosciences, Inc. (-70.58%), greater than Cullinan Oncology, Inc. (-29.47%), greater than Annexon, Inc. (-54.45%), greater than Relay Therapeutics, Inc. (-44.16%),

Build a custom stock screener for Ligand Pharmaceuticals Incorporated (LGND) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ligand Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ligand Pharmaceuticals Incorporated (LGND) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ligand Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.